Physician profile
David Wayne Clause
NPI 1184701526
$5,473.93
in general payments reported to CMS, 2019-2025
10 companies · $45.10 in 2025
The $45.10 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.22 · 2020: $1,869 · 2021: $2,688 · 2022: $650 · 2023: $115 · 2024: $32.43 · 2025: $45.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $3,309.00 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $1,840.61 | 2020 | |
| Dentsply Sirona INC | $106.32 | 2019-2023 | Cavitron |
| Solventum Corporation | $61.00 | 2024-2025 | Vanish Varnish, 3m Filtek |
| Nobel Biocare USA | $60.32 | 2023 | Nobelactive |
| Kerr Corporation | $35.65 | 2020-2023 | K3 |
| Gc America INC. | $16.53 | 2025 | Equia, Gc Fujicem, G-Aenial |
| Implant Direct Sybron International LLC | $15.08 | 2021 | |
| Philips North America LLC | $14.80 | 2019 | |
| 3m Company | $14.62 | 2023 | 3m Espe Filtek Supreme Ultra Universal Restorative |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Clause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.